ASX:COHMedical Equipment
Cochlear (ASX:COH) Valuation Check After Guidance Cut And Global Demand Challenges
Cochlear (ASX:COH) is back in focus after the company cut its fiscal year profit guidance, citing softer demand in the US, surgical capacity constraints in Western Europe, and external risks in China and the Middle East.
See our latest analysis for Cochlear.
The steep guidance cut has been met with a sharp reset in sentiment, with a 7 day share price return of 42.21% decline and a 1 year total shareholder return of 62.47% decline pointing to fading momentum, even as management reiterates its...